BAT
Sponsors
Chang Gung Memorial Hospital, Emergent BioSolutions, Helsinki University Central Hospital, RWTH Aachen University, GlaxoSmithKline
Conditions
ARDS, HumanAcute Graft-versus-host DiseaseAcute PyelonephritisBotulismCOVID19Cerebrovascular AccidentComplicated Intra-abdominal InfectionComplicated Urinary Tract Infection
Phase 1
Phase 2
The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia
Active, not recruitingNCT02577926
Start: 2015-10-31End: 2028-12-31Updated: 2025-06-10
Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
CompletedNCT04366908
Start: 2020-05-07End: 2022-04-19Updated: 2023-03-03
Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients
TerminatedNCT04954014
Start: 2020-09-01End: 2021-08-31Updated: 2021-09-05
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
RecruitingNCT05639647
Start: 2023-04-18End: 2026-08-17Target: 48Updated: 2026-03-25
PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
CompletedNCT05685615
Start: 2023-04-20End: 2024-12-11Updated: 2025-01-14
Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease
Active, not recruitingNCT06075706
Start: 2023-11-13End: 2031-06-01Target: 48Updated: 2026-01-27
Phase 3
Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria
TerminatedNCT03580044
Start: 2020-12-25End: 2023-01-23Updated: 2024-02-02
Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy
RecruitingNCT04629833
Start: 2021-08-16End: 2030-08-31Target: 210Updated: 2025-08-13
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
CompletedNCT05905055
Start: 2023-09-22End: 2025-09-01Updated: 2026-03-19
Unknown Phase
Combined Behavioral Approaches With Functional Electrical Therapy in Stroke Rehabilitation
WithdrawnNCT01523925
Start: 2012-01-31End: 2013-03-31Updated: 2015-02-11
BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin
CompletedNCT02055183
Start: 2014-10-31End: 2017-07-31Updated: 2024-03-15
The Effect of BATon BP and Sympathetic Function in Resistant Hypertension (The Nordic BAT Study)
CompletedNCT02572024
Start: 2015-11-30End: 2023-03-31Target: 100Updated: 2023-03-02
A Clinical Study of Bacillus Coagulans in Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
Not yet recruitingNCT06593834
Start: 2024-09-27End: 2026-04-30Target: 286Updated: 2024-09-25